(Q38059884)

28 August 2017

Recent advances in ocular drug delivery (English)

1 reference

28 August 2017

1 reference

Djamila Achouri

1

1 reference

28 August 2017

Kamel Alhanout

series ordinal

2

1 reference

28 August 2017

Philippe Piccerelle

series ordinal

3

1 reference

28 August 2017

Véronique Andrieu

series ordinal

4

1 reference

28 August 2017

language of work or name

English

0 references

publication date

16 November 2012

1 reference

Drug Development and Industrial Pharmacy

28 August 2017

1 reference

28 August 2017

39

1 reference

28 August 2017

1599-1617

1 reference

28 August 2017

11

1 reference

Pharmacokinetics of topically applied ophthalmic drugs

28 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Cationic vectors in ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Recent patents and advances in ophthalmic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Recent advances in ophthalmic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Ocular preparations: the formulation approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Role of cyclodextrins in ophthalmics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Reduction in intraocular pressure by the instillation of eye drops containing disulfiram included with 2-hydroxypropyl-β-cyclodextrin in rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

In situ-forming hydrogels for sustained ophthalmic drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Ophthalmic drug delivery systems--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

The use of mucoadhesive polymers in ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Recent advances in developing ophthalmic formulations: a patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Studies on In situ Hydrogel: A Smart Way for Safe and Sustained Ocular Drug Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Ocular hypotensive efficacy and safety of once daily carteolol alginate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Preparation and evaluation of sustained ophthalmic gel of enoxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Stimuli-sensitive hydrogels: a novel ophthalmic drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Preparation and ocular pharmacokinetics of ganciclovir liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Liposomes as an ocular delivery system of fluconazole: in-vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Preparation and evaluation of thermosensitive liposomal hydrogel for enhanced transcorneal permeation of ofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Ciprofloxacin as ocular liposomal hydrogel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Freeze-dried liposomes as potential carriers for ocular administration of cytochrome c against selenite cataract formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Topical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Niosome-encapsulated gentamicin for ophthalmic controlled delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

21 January 2018

Cubosomes: an overview

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

New vehicle based on a microemulsion for topical ocular administration of dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Hyaluronic acid coated poly-epsilon-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Mucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

Nanoceria have no genotoxic effect on human lens epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2012.736515

10.3109/03639045.2012.736515

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference